ABCLNasdaqPharmaceutical PreparationsFiscal year ends December 31
AbCellera Biologics Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$11.93+0.13 (+1.10%)
Close on Oct 19, 2026
- Market cap
- $3.65B
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of AbCellera Biologics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Aug 12, 2026 | Aug 13, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 10, 2026 | Aug 10, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 7, 2026 | Aug 7, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 5, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 5, 2026 | Aug 5, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 29, 2026 | Jul 29, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 30, 2026 | Jul 6, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 17, 2026 | Jun 17, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 11, 2026 | Jun 12, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 1, 2026 | Jun 5, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 11, 2026 | SEC EDGAR |
| Current report | 8-K | May 11, 2026 | May 11, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Dec 31, 2025 | Apr 29, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Feb 24, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 24, 2026 | Feb 24, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 12, 2026 | Jan 14, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 18, 2025 | Dec 18, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 24, 2025 | Nov 28, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 10, 2025 | Nov 12, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 6, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 6, 2025 | Nov 6, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 10, 2025 | Sep 10, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 7, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 7, 2025 | Aug 7, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 12, 2025 | Jun 13, 2025 | SEC EDGAR |
| Current report | 8-K | May 30, 2025 | May 30, 2025 | SEC EDGAR |
| Current report | 8-K | May 14, 2025 | May 14, 2025 | SEC EDGAR |
| Current report | 8-K | May 12, 2025 | May 13, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 8, 2025 | SEC EDGAR |
| Current report | 8-K | May 8, 2025 | May 8, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Dec 31, 2024 | Apr 29, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Feb 27, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 27, 2025 | Feb 27, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 18, 2025 | Feb 18, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 4, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 4, 2024 | Nov 4, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 6, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 6, 2024 | Aug 6, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 13, 2024 | Jun 13, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 7, 2024 | SEC EDGAR |